Background: Evidence suggests that low levels of Vitamin D may adversely affect the cardiovascular (CV) system. Several studies have been done regarding the relation and possible causative role of Vitamin D in CV disorders and its well-known risk factors; however, there are limited studies in this part of the world. The aims were as follows: (1) To study the relation between serum Vitamin D level between nonhypertensive and hypertensive patients. (2) To study the relation of serum Vitamin D levels in patients with isolated systolic hypertension (ISH), isolated diastolic hypertension, systolo-diastolic hypertension, and their comparison vis-à-vis nonhypertensives. Materials and Methods: A cross-sectional study was conducted with 154 patients attending medicine outpatient department of a tertiary care hospital of North Bengal from June 2012 to May 2013. The Vitamin D was measured by direct ELISA method. Blood pressure (BP) measurements were done. Statistical analysis was done by using SPSS 16.0 for Windows. Results: The Vitamin D level in the hypertensive group was 22.36 ± 12.64; ISH Group was 22.04 ± 14.26; the isolated diastolic hypertension (IDH) Group was 18.82 ± 0.00; and the systolo-diastolic hypertensives (SDH) Group was 22.67 ± 12.51. Then, the mean value of Vitamin D in nonhypertensive Group (27.47 ± 13.43) was significantly (P < 0.05) higher than IDH, SDH, and the hypertensive as a whole groups. The relation with ISH Group also reached near significance (P = 0.074). There was a negative correlation with BP and serum Vitamin D. This remained statistically significant (P = 0.044) for systolic BP (SBP) and near significant (P = 0.075) for mean arterial pressure. In population having serum Vitamin D <30 ng/ml (deficient or insufficient), the negative correlation relationship between SBP and serum Vitamin D remains statistically significant (P = 0.010). Conclusion: Among the hypertensives, SDH shows significantly lower levels of serum Vitamin D. The patients with ISH show a trend, though not statistically significant, toward a lower level of Vitamin D compared to the nonhypertensive population.
Introduction
Vitamin D is an essential component of our body. A growing body of evidence suggests that low levels of Vitamin D may adversely affect the cardiovascular (CV) system. [1] Low levels of 25-hydroxyvitamin D (25[OH]D) are associated with many markers of CV disease; for example, hypertension, increased vascular resistance, and increased left ventricular mass index. [2] [3] [4] In addition, 25(OH)D levels correlate inversely with coronary calcification, an indicator of atherosclerosis, and a precursor of CV events. [5] Deficient or insufficient serum 25(OH)D levels have been documented in patients with myocardial infarction, heart failure, stroke, diabetic CV disease, and peripheral arterial disease. [6] [7] [8] [9] [10] Till date, several studies have been done regarding the relation and possible causative role of Vitamin D in CV disorders and its well-known risk factors; however, there are limited studies in this part of the world. Hypertension itself is an independent risk factor for many CV and neurological disorders. In this study, we will find out the relationship between the 25(OH)D level and hypertension in persons attending the medicine outpatient department (OPD) of a tertiary care hospital in North Bengal.
A study of serum Vitamin D level and its association with hypertension

Materials and Methods
This cross-sectional study was conducted at the medicine OPD of a tertiary care hospital of North Bengal from June 2012 to May 2013. The patients aged >40 years with any grade of hypertension and normotension without any clinically apparent cardiac, hepatic, neurologic, or renal disorder were included in the study. Simple active infections were corrected before inclusion. The patients having diabetes mellitus, abnormal renal function, (estimated glomerular filtration rate <60 ml/min/1.73 m 2 by Modification of Diet in Renal Disease formula, [11] clinical or laboratory evidence of secondary hypertension, already on Vitamin D supplement and/or steroid therapy, chronic inflammatory conditions, abnormal resting electrocardiography (ECG), abnormal liver function tests (LFTs), abnormal thyroid function, and patients not giving consent for the study were excluded from the study.
A total of 154 patients were selected for the study. Assuming the prevalence of Vitamin D deficiency 50% (P) in n population, the sample size was calculated by applying the formula
where Zα = 1.96. P = 50%. L = Absolute allowable error (8%).
Considering a 20% attrition rate initially a total of 180 patients were selected by systematic random sampling. Among those attending medicine OPD, every 10 th patient was selected as a sample in a specified weekday, every week. Data collection was done from August 2012 to January 2013. Among those selected, 21 were excluded from the study due to calculated GFR <60; three having hypothyroidism, and two did not give consent. Hence, the final number of the sample was 154.
History taking
• Age, sex, and religion (Hindu, Muslim, and Others) of the participants were noted as per voter ID card • Dietary pattern was classified as nonvegetarian and vegetarian • Sunlight exposure was quantified as average hours of direct sunlight per day based on direct questioning • Smoking status was defined as smokers and nonsmokers.
Smokers Group included current smoker (having regular smoking in the preceding year -any number of bidi, cigarette) and former smoker (quit smoking 1 year back) [12] • Alcohol addiction was defined as patients taking at least one or two standard drink per week. One standard drink [13] equals to 340 mL (12 oz) of beer, 115 mL (4 oz) of nonfortified wine, and 43 mL (1.5 oz) (a shot) of 80 proof beverages such as whisky, gin, or vodka each contain 10-15 g of ethanol and ~ 30-40 ml of Country liquor. Nondrinker was defined to those having never taken a drink or social drinker with lesser frequency than the previously mentioned values
• Diabetes was defined as per the American Diabetes
Association Guidelines 2011.
Measurements
Blood pressure Blood pressure (BP) was measured in the sitting position using a mercury sphygmomanometer. Patients were kept seated quietly for at least 5 min in a chair with feet on the floor and arm supported at heart level. Caffeine, exercise, and smoking were avoided for at least 30 min before measurement. An appropriately sized cuff (cuff bladder encircling at least 80 percent of the arm) was used to ensure accuracy. At least, two measurements were taken, and the average was recorded. For manual determinations, palpated radial pulse obliteration pressure was used to estimate systolic BP (SBP)-the cuff was inflated 20-30 mmHg above this level for the auscultatory determinations; the cuff deflation rate for auscultatory readings was 2 mmHg per second. SBP is the point at which the first of two or more Korotkoff sounds was heard (onset of phase 1), and the disappearance of Korotkoff sound (onset of phase 5) was used to define diastolic BP (DBP).
The hypertension categories were defined [14, 15] as follows: 
Height, weight, body mass index, and waist circumference
Body weight (kg) was measured without upper clothes and shoes using a calibrated balance beam scale. Height (cm) was measured using a stadiometer. Body mass index (BMI) was calculated by weight divided by height squared (kg/m 2 ). BMI >18.5 ≤24.9 was considered as normal, BMI ≤18.5 was considered underweight, BMI ≥25 ≤29.9 overweight, BMI ≥30 obesity. Waist circumference (cm) was measured midway between the lower rib margin and the iliac crest following a normal expiration. [16] Vitamin D Blood samples were obtained and centrifuged immediately to separate the serum portion. Patients were allowed to have tea and toast, but no dairy products before blood sampling. These samples were analyzed either within 30 min of collection or in case of expected delay, were stored at −40°C for analyzing later on. [17] Deficiency (moderate, severe), insufficiency, and sufficient (normal) level.
Other investigations
Other laboratory tests and/or imaging studies were done when indicated to rule out secondary hypertension.
• Ultrasonography (USG) of the kidney, ureter, and bladder:
To look for kidney size (by Philips HD7 machine) • USG Doppler study of renal artery (as and when necessary)
• Fasting blood sugar, postprandial blood sugar, T 3 T 4 , TSH, Na+, K+, creatinine, LFT, ECG.
Statistical analysis of data
The data were entered in Microsoft Office Excel Worksheet and expressed as mean ± standard deviation for continuously distributed variables and in absolute numbers and percentages for discrete variables. 
Results
The present study included 154 patients. There were 98 male (63.63%) and 56 (36.37%) female patients. The mean age of the participants in this study was 53.45 (±10.661). The mean age of the male participants was 55.73 (±11.156) while that of the female participants was 49.45 (±8.427) [ Table 2 ].
In our study, the prevalence of hypertension was 53.24% in total. For male and female population, the figure was 53.06% and 53.57%, respectively [ Table 3 ].
Correlation analysis [ Table 4 ] between systolic, diastolic, and MAP with serum Vitamin D level shows that there was a negative correlation with BP and Serum Vitamin D though the relation remained statistically significant (P = 0.044) for systolic BP and near significant (P = 0.05-0.09) for MAP.
As other covariates such as age, sunlight exposure, and waist circumference were also having a significant correlation with SBP and MAP [ Table 4 ], Multivariate linear regression analysis was performed after adjusting for those variables.
In population having serum Vitamin D < 30 ng/ml (deficient or insufficient), the negative correlation relationship between SBP and serum Vitamin D remains statistically significant (P = 0.010), i.e., Vitamin D had an independent negative impact on SBP [ Table 5 1 ng/ml=2.5 nmol/l, 1 nmol/l=0.4 ng/ml 
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